Harmony Biosciences CMO Budur Kumar disposes of USD 1.43 million in common shares
Reuters2026/09/09 21:13- Harmony Biosciences Chief Medical Officer Budur Kumar cut his stake to 13,115 common shares in transactions dated Sept. 4-8.
- Disposed of 33,954 shares at weighted-average prices of USD 41.98 to USD 43.1 per share.
- Exercised stock options for 22,954 shares at USD 30.69 and USD 30.27 per share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
JPMorgan resumes coverage of Lithium Americas (LAC.US) and upgrades to "Overweight", target price of $6.
Lithium Americas (LAC.US) shares rose 6% on Wednesday after JPMorgan resumed coverage and raised its rating to "Overweight" with a target price of $6.

Charlie Hospital Semarang says no material information behind share-price volatility
Venteny Fortuna International files corrected annual public expose materials
Abu Dhabi Mubadala Strategic Investment in Luckin Coffee Explained: Transfer of Preferred Shares by New and Old Funds, Transaction Size Around 1 billion USD
The beneficial ownership of Dachen remains unchanged.